2021•Journal of Cystic FibrosisOpen access

573: Direct lytic agents exert potent bactericidal activity vs gram-negative pathogens causing pulmonary infections in CF patients, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans

Jeung-Haing Oh, A. Watson, Karen Sauve, Simon Swift, Jane E. Ambler, Cara Cassino, John J. LiPuma, R. Schuch

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Stenotrophomonas maltophilia, Pseudomonas aeruginosa, Microbiology, Achromobacter xylosoxidans, Medicine, Stenotrophomonas, Cystic fibrosis, Lytic cycle

Back to paper search Browse research topics Original source

573: Direct lytic agents exert potent bactericidal activity vs gram-negative pathogens causing pulmonary infections in CF patients, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans — Research Paper | ScholarLens